Latest Advanced Medical Iso (ADMD) Headlines
Advanced Medical Isotope Corporation Provides Progress Report on FDA Pre-Market Notification Application
PR Newswire - Fri Feb 21, 8:22PM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.
Concise Analysis of the International Radiopharmaceuticals Market
M2 - Fri Feb 14, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/5ltj8g/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - France (2) - Germany (2) - The United Kingdom (4) - Italy (2) - Spain (1) - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5l...rmaceutica
Advanced Medical Isotope Corporation Announces that it will present at "TEN;" Noble Financial Capital Markets' Tenth Annual Equity Conference on January 22
PR Newswire - Wed Jan 15, 6:22AM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that its CEO, James C. Katzaroff, will present AMIC's corporate overview at "TEN;" Noble Financial Capital Markets' Tenth Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Wednesday, January 22, 2014 at 8:30am Eastern Time.
Advanced Medical Isotope Corporation Announces Three Year Business Strategy Focused on Transitioning From a Development-Stage Company to an Operating Company
GlobeNewswire - Mon Dec 02, 6:22AM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that its Board of Directors has approved a three year business strategy focused on transitioning to full operations in 2014, following the anticipated receipt of FDA clearance for its patented brachytherapy cancer product, Yttrium-90 RadioGel.
Advanced Medical Isotope Corporation to Discuss Third Quarter 2013 Financial Results and Provide a General Business Update
GlobeNewswire - Fri Nov 15, 9:22AM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that the Company will host a teleconference to discuss its Third Quarter 2013 financial results and to provide a general business update on November 18, 2013.
In Depth Stock Reports On SOPW, JAGGF, ADMD and ISDR
ACCESSWIRE - Thu Nov 07, 5:36AM CST
Solar Power, Inc. (OTC: SOPW), Jaguar Mining Inc. (OTC: JAGGF), Advanced Medical Isotope Corp. (OTC: ADMD) and Issuer Direct Corp. (OTC: ISDR) have been added to our watch list.
James C. Katzaroff, CEO & Founder of Advanced Medical Isotope Corporation, is Featured in a New Audio Interview at SmallCapVoice.com
GlobeNewswire - Wed Nov 06, 5:16PM CST
SmallCapVoice.com, Inc. announced today that a new audio interview with Advanced Medical Isotope Corporation (OTCQB:ADMD) is now available. The interview can be heard at http://smallcapvoice.com/blog/11-6-13-smallca...-corp-admd
Advanced Medical Isotope Corporation Files 510(k) Pre-Market Notification for FDA Clearance of Yttrium-90 RadioGel(TM) Brachytherapy Product
GlobeNewswire - Sun Nov 03, 6:22PM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that it has filed pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 RadioGel(TM) patented brachytherapy cancer product.
Kenin M. Spivak Elected Vice Chairman of Board of Directors of Advanced Medical Isotope Corporation
GlobeNewswire - Fri Oct 11, 8:30AM CDT
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, today announced that Kenin M. Spivak has been elected to its board of directors as vice-chairman of the board. Concurrently, AMIC has modified and extended its consulting agreement with Spivak Management Inc. ("SMI").
UPDATE -- Advanced Medical Isotope Management to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
GlobeNewswire - Thu Aug 15, 3:01PM CDT
Advanced Medical Isotope Corporation (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, will host a teleconference to discuss its second quarter financial results and to provide a business update.
Advanced Medical Isotope Management to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
GlobeNewswire - Thu Aug 15, 1:37PM CDT
Advanced Medical Isotope Corporation (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, will host a teleconference to discuss its second quarter financial results and to provide a business update.
Advanced Medical Isotope Management to Give Update
GlobeNewswire - Tue Aug 13, 10:26AM CDT
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, will hold an investor call at 10 am pacific on Tuesday, August 13. Call in number is 800.839.9416 and pin is 1318768.
Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
M2 - Fri Aug 02, 9:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xckkfp/radiopharmaceutica#summary) has announced the addition of the "Radiopharmaceuticals - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Key Topics Covered: Click the link below to view the full extended table of contents and list of companies featured. I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - - France (2) - - Germany (2) - - The United Kingdom (4) - - Italy (2) - - Spain (1) - - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/xc...ca#summary
Advanced Medical Isotope Corporation Engages Barry Kaplan Associates to Enhance Financial Market
GlobeNewswire - Thu Jun 20, 6:22AM CDT
Advanced Medical Isotope Corporation (OTCBB:ADMD) today announced that it has retained the services of Barry Kaplan Associates ("BKA"), of Fair Haven, New Jersey to enhance financial market relations. BKA has agreed to assist Advanced Medical Isotope Corporation by preparing background documentation regarding the company and arranging for investor and media presentations, with monthly meetings to increase awareness of Advanced Medical Isotope Corporation in the financial marketplace.
AMIC Enters Into Strategic Alliance With GSG International
GlobeNewswire - Tue Mar 26, 6:22AM CDT
- Worldwide Distribution Agreement Covers Key Medical Isotopes -
Advanced Medical Isotope Update on RadioGel
GlobeNewswire - Tue Feb 05, 6:22AM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, has submitted data on its RadioGel device to the FDA and requested a collaborative meeting.
Advanced Medical Isotope Corporation Provides Progress Report on FDA Pre-Market Notification Application
PR Newswire - Fri Feb 21, 8:22PM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that it has received a response from the FDA to its pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 (Y-90) RadioGel(tm) patented brachytherapy cancer product.
Concise Analysis of the International Radiopharmaceuticals Market
M2 - Fri Feb 14, 5:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/5ltj8g/radiopharmaceutica) has announced the addition of the "Concise Analysis of the International Radiopharmaceuticals Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - France (2) - Germany (2) - The United Kingdom (4) - Italy (2) - Spain (1) - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/5l...rmaceutica
Advanced Medical Isotope Corporation Announces that it will present at "TEN;" Noble Financial Capital Markets' Tenth Annual Equity Conference on January 22
PR Newswire - Wed Jan 15, 6:22AM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB: ADMD), a company engaged in the development, production and distribution of medical isotopes focused on yttrium-90 brachytherapy devices, today announced that its CEO, James C. Katzaroff, will present AMIC's corporate overview at "TEN;" Noble Financial Capital Markets' Tenth Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Wednesday, January 22, 2014 at 8:30am Eastern Time.
Advanced Medical Isotope Corporation Announces Three Year Business Strategy Focused on Transitioning From a Development-Stage Company to an Operating Company
GlobeNewswire - Mon Dec 02, 6:22AM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that its Board of Directors has approved a three year business strategy focused on transitioning to full operations in 2014, following the anticipated receipt of FDA clearance for its patented brachytherapy cancer product, Yttrium-90 RadioGel.
Advanced Medical Isotope Corporation to Discuss Third Quarter 2013 Financial Results and Provide a General Business Update
GlobeNewswire - Fri Nov 15, 9:22AM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that the Company will host a teleconference to discuss its Third Quarter 2013 financial results and to provide a general business update on November 18, 2013.
In Depth Stock Reports On SOPW, JAGGF, ADMD and ISDR
ACCESSWIRE - Thu Nov 07, 5:36AM CST
Solar Power, Inc. (OTC: SOPW), Jaguar Mining Inc. (OTC: JAGGF), Advanced Medical Isotope Corp. (OTC: ADMD) and Issuer Direct Corp. (OTC: ISDR) have been added to our watch list.
James C. Katzaroff, CEO & Founder of Advanced Medical Isotope Corporation, is Featured in a New Audio Interview at SmallCapVoice.com
GlobeNewswire - Wed Nov 06, 5:16PM CST
SmallCapVoice.com, Inc. announced today that a new audio interview with Advanced Medical Isotope Corporation (OTCQB:ADMD) is now available. The interview can be heard at http://smallcapvoice.com/blog/11-6-13-smallca...-corp-admd
Advanced Medical Isotope Corporation Files 510(k) Pre-Market Notification for FDA Clearance of Yttrium-90 RadioGel(TM) Brachytherapy Product
GlobeNewswire - Sun Nov 03, 6:22PM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the development, production and distribution of medical isotopes, today announced that it has filed pre-market notification to the FDA pursuant to Section 510(k) of the U.S. Food, Drug and Cosmetic Act for its Yttrium-90 RadioGel(TM) patented brachytherapy cancer product.
Kenin M. Spivak Elected Vice Chairman of Board of Directors of Advanced Medical Isotope Corporation
GlobeNewswire - Fri Oct 11, 8:30AM CDT
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, today announced that Kenin M. Spivak has been elected to its board of directors as vice-chairman of the board. Concurrently, AMIC has modified and extended its consulting agreement with Spivak Management Inc. ("SMI").
UPDATE -- Advanced Medical Isotope Management to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
GlobeNewswire - Thu Aug 15, 3:01PM CDT
Advanced Medical Isotope Corporation (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, will host a teleconference to discuss its second quarter financial results and to provide a business update.
Advanced Medical Isotope Management to Discuss Second Quarter 2013 Financial Results and Provide a Business Update
GlobeNewswire - Thu Aug 15, 1:37PM CDT
Advanced Medical Isotope Corporation (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, will host a teleconference to discuss its second quarter financial results and to provide a business update.
Advanced Medical Isotope Management to Give Update
GlobeNewswire - Tue Aug 13, 10:26AM CDT
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, will hold an investor call at 10 am pacific on Tuesday, August 13. Call in number is 800.839.9416 and pin is 1318768.
Global Strategic Business Radiopharmaceuticals Report 2013-2018: High Costs of Drug Development Piques Manufacturers
M2 - Fri Aug 02, 9:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xckkfp/radiopharmaceutica#summary) has announced the addition of the "Radiopharmaceuticals - Global Strategic Business Report" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Million by the following Product Segments: - Diagnostic Radiopharmaceuticals - Therapeutic Radiopharmaceuticals. The report profiles 69 companies including many key and niche players such as: - Actinium Pharmaceuticals Inc. - Advanced Medical Isotope Corporation - Alseres Pharmaceuticals Inc. - Bayer HealthCare Pharmaceuticals - Bracco Diagnostics Inc. - Cardinal Health Inc. - Covidien Plc - Eli Lilly and Company - Erigal Limited - EUSA Pharma (Europe) Ltd. - GE Healthcare - IBA Group - Immunomedics Inc. - Jubilant Life Sciences Limited - Lantheus Medical Imaging Inc. - Medi-Radiopharma Ltd. - Nordion Inc. - Peregrine Pharmaceuticals Inc. - PETNET Solutions Inc. - Positron Corporation - Singapore Radiopharmaceuticals Pte Ltd. - Triad Isotopes Inc. Key Topics Covered: Click the link below to view the full extended table of contents and list of companies featured. I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Growth Drivers & Trends 3. Market Challenges 4. Therapeutic Radiopharmaceutical Products Under Development 5. Imaging Agents - An Overview 6. Nuclear Medicine - An Overview 7. Product Overview 8. Product Innovations/Introductions 9. Product Innovations/Introductions In Recent Past- A Perspective Builder 10. Recent Industry Activity 11. Corporate Activity In The Recent Past - A Perspective Builder 12. Focus On Select Players 13. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 69 (including Divisions/Subsidiaries - 79) - The United States (36) - Canada (2) - Japan (1) - Europe (28) - - France (2) - - Germany (2) - - The United Kingdom (4) - - Italy (2) - - Spain (1) - - Rest of Europe (17) - Asia-Pacific (Excluding Japan) (9) - Latin America (1) - Africa (1) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/xc...ca#summary
Advanced Medical Isotope Corporation Engages Barry Kaplan Associates to Enhance Financial Market
GlobeNewswire - Thu Jun 20, 6:22AM CDT
Advanced Medical Isotope Corporation (OTCBB:ADMD) today announced that it has retained the services of Barry Kaplan Associates ("BKA"), of Fair Haven, New Jersey to enhance financial market relations. BKA has agreed to assist Advanced Medical Isotope Corporation by preparing background documentation regarding the company and arranging for investor and media presentations, with monthly meetings to increase awareness of Advanced Medical Isotope Corporation in the financial marketplace.
AMIC Enters Into Strategic Alliance With GSG International
GlobeNewswire - Tue Mar 26, 6:22AM CDT
- Worldwide Distribution Agreement Covers Key Medical Isotopes -
Advanced Medical Isotope Update on RadioGel
GlobeNewswire - Tue Feb 05, 6:22AM CST
Advanced Medical Isotope Corporation ("AMIC") (OTCBB:ADMD), a company engaged in the production and distribution of medical isotopes, has submitted data on its RadioGel device to the FDA and requested a collaborative meeting.
